Navigation Links
Data on VIVUS' QNEXA to be Presented in Six Posters at The Obesity Society's Annual Meeting
Date:10/7/2010

MOUNTAIN VIEW, Calif., Oct. 7 /PRNewswire/ -- VIVUS, Inc. (Nasdaq: VVUS) today announced that data on QNEXA®, an investigational drug candidate, are highlighted in six poster presentations at the 28th Annual Scientific Meeting of The Obesity Society, being held October 8-12, 2010 in San Diego, California.

Following are details about the poster presentations:

The Obesity Society 28th Annual Scientific Meeting at The San Diego Convention Center in San Diego, CA

All six posters will be presented in Poster Session #2 (Hall H) on Sunday, October 10, 2010 from 9:30 am to 1:45 pm and from 3:15 pm to 6:30 pm.  

Presenters will be at their posters from 12:30 pm to 1:30 pm. Presenter:

Wesley W. Day, PhDAuthors:

Day, Najarian, Troupin, Tam, PetersonTitle:

Low-Dose, Controlled-Release Phentermine/Topiramate Reduces Hunger and Increases Satiety, Leading to Weight Loss in Overweight/Obese Adults (Abstract # 212898; Poster # 490-P)Presenter:

Kishore M. Gadde, MDAuthors:

Gadde, Peterson, DayTitle:

Clinically Meaningful Weight-Loss Outcomes With Low-Dose, Controlled-Release Phentermine/Topiramate in Overweight/Obese Subjects (Abstract # 212885; Poster #486-P)Presenter:

Dympna Gallagher, EdDAuthors:

Gallagher, Punyanitya, Bowden, PetersonTitle:

Low-Dose, Controlled-Release Phentermine/Topiramate Reduces Adiposity, Improves Cardiometabolic Risk in Overweight/Obese Patients (Abstract # 212891; Poster # 488-P)Presenter:

W. Timothy Garvey, MDAuthors:

Garvey, Peterson, Troupin, BowdenTitle:

Low-Dose, Controlled-Release Phentermine/Topiramate for Weight Loss and Management of Type 2 Diabetes Mellitus (Abstract # 212889; Poster # 492-P)Presenter:

Samuel Klein, MDAuthors:

Klein, Najarian, DayTitle:

Weight Loss With Once-Daily, Low-Dose, Controlled-Rele
'/>"/>

SOURCE VIVUS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. VIVUS Reports First Quarter 2009 Financial Results and Highlights
2. Data on VIVUS Qnexa To Be Presented During Two Podium Presentations at ADA Annual Meeting
3. VIVUS to Present at the Needham and Company Life Sciences Conference
4. VIVUS to Present at the Canaccord Adams 29th Annual Global Growth Conference
5. VIVUS to Present at Four Upcoming Healthcare Conferences
6. VIVUS Announces Positive Results From Two Phase 3 Studies; Obese Patients on Qnexa Achieve Average Weight Loss up to 14.7% and Significant Improvements in Co-Morbidities
7. VIVUS Reports Third Quarter 2009 Highlights and Financial Results
8. VIVUS to Present at Two Upcoming Investor Conferences
9. VIVUS to Present at Four Upcoming Investor Conferences
10. Vascular Biogenics Ltd. Presented With the Frost & Sullivan 2008 European Gene Expression Targeting Platform Technology Innovation Award
11. ApoA-I Data Presented at European Society of Cardiology Congress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... 5, 2015  Orexigen Therapeutics, Inc. (Nasdaq: OREX ... 2015 on Friday, May 8 before the market opens. ... and conference call at 8:30 a.m. Eastern Time (5:30 ... be accessed by phone by calling (800) 708-4540 (domestic) ... can be accessed live on the Investors section of ...
(Date:5/5/2015)... CA (PRWEB) May 05, 2015 Synedgen ... Nguyen, PhD as Regulatory Affairs Manager. , Dr. Nguyen ... an important juncture for the company as it moves ... drug products over the next two years. Dr. Nguyen ... of all the regulatory key documents that must be ...
(Date:5/4/2015)... 4, 2015   St. Jude Children,s Research ... computer tool for finding genetic alterations that play ... difficult to identify with whole-genome sequencing. The findings ... Methods . The tool is an ... by Regression Tree in Next Generation Sequencing. ...
(Date:5/4/2015)... - The Fight Against Cancer Innovation Trust (FACIT) ... formation of Turnstone Biologics Inc. (Turnstone), a biotechnology ... harness the patient,s own immune system. ... Children,s Hospital of Eastern Ontario ... Institute for Cancer Research (OICR), the Ottawa Hospital ...
Breaking Biology Technology:Synedgen Announces the Appointment of Regulatory Affairs Manager 2Scientists dramatically improve method for finding common genetic alterations in tumors 2Scientists dramatically improve method for finding common genetic alterations in tumors 3Scientists dramatically improve method for finding common genetic alterations in tumors 4Turnstone Biologics Inc. to accelerate clinical and commercial translation of cancer immunotherapies 2Turnstone Biologics Inc. to accelerate clinical and commercial translation of cancer immunotherapies 3
... Brinks Hofer Gilson & Lione, one of the,largest intellectual ... new office in the Raleigh/Durham, North Carolina area and welcomes ... who will be,based in the Raleigh office. Mr. Baum and ... as partners. The office will officially,be open for business on ...
... N.J., July 9 Par,Pharmaceutical Companies, Inc. (NYSE: ... 12.5mg and 25mg meclizine HCl tablets immediately. At,this time, ... AB-rated,generic product., Par marketed meclizine prior to an ... 2008. Par has since qualified a new API source ...
... Inc. (Nasdaq: ALXA ) announced today that ... Global Supply Chain and,Sustainment Engineering. He will have ... global supply chain strategy to,support the commercialization of ... AZ-004 (Staccato(R) loxapine) is in,Phase 3 clinical testing ...
Cached Biology Technology:Brinks Hofer Gilson & Lione Expands to High-Tech Raleigh/Durham Area; Adds Accomplished Patent Attorneys to Its New Office 2Brinks Hofer Gilson & Lione Expands to High-Tech Raleigh/Durham Area; Adds Accomplished Patent Attorneys to Its New Office 3Par Pharmaceutical to Launch meclizine HCL Tablets 2Christopher Kurtz Joins Alexza Pharmaceuticals as Vice President, Global Supply Chain and Sustainment Engineering 2Christopher Kurtz Joins Alexza Pharmaceuticals as Vice President, Global Supply Chain and Sustainment Engineering 3
(Date:4/2/2015)... At its 2015 ACMG Annual Clinical Genetics ... the American College of Medical Genetics and Genomics (ACMG) ... Board.  Members of the ACMG Board of Directors serve ... advancing its policies and programs. ACMG is the national ... an eventful time in medical genetics and genomics.  We ...
(Date:4/2/2015)... , April 2, 2015 ... touch fingerprint sensor FPC1025 from the distributor World Peace ... commence during Q2 2015 although the major part of ... sensors will be used by smartphone manufacturers in ... MSEK is included in the communicated revenue guidance of ...
(Date:4/1/2015)... --  Medisafe ™, the leading global medication management platform ... and Android smartphones and tablets, announces today ... to allow patients to track and correlate their adherence ... will be able to visualize in real-time how taking ... as glucose levels and blood pressure. "Patients ...
Breaking Biology News(10 mins):American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 3American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 4American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 5American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 6American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 7American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 8Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 110 Million 2Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2
... The biggest ever single UK public investment in bioenergy ... main funding agency for the biosciences the Biotechnology ... 27M BBSRC Sustainable Bioenergy Centre has been launched to ... and emerging UK sustainable bioenergy sector and to ...
... Switzerland, Jan. 26 SVOX, the leading provider ... the Professional,Speech Processing Group of Siemens AG, according ... speech technology-related IP of Siemens AG developed,over 25 ... more than 60 patent families. The majority of ...
... Spring Harbor Laboratory (CSHL) announced today the discovery of ... time, they reported that their discovery suggests the presence ... in which these and possibly other small RNAs are ... project called ENCODE, also provided information concerning the biological ...
Cached Biology News:Biggest ever public investment in bioenergy to help provide clean, green and sustainable fuels 2SVOX Acquires Speech Processing Unit of Siemens AG, Expands Into Speech Recognition and Speech Dialog 2CSHL scientists find a new class of small RNAs and define its function 2CSHL scientists find a new class of small RNAs and define its function 3
... PROTEAN II xi 2-D system runs both gel dimensions ... tube gels can be separated in a single run ... cooling core in much the same manner as the ... the second-dimension slab gels may be cast in the ...
... all the accessories necessary for casting gels ... analysis (SSCP) with the DCode universal mutation ... finger adaptor for use with an external ... cm plates, 2 sets of 0.75 mm ...
...
...
Biology Products: